This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Akesion Gmbh, Basf Aktiengesellschaft. Active years: 2000-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2020
Title: Klaus Rübsamen: Innovator in Medical Biotechnology
Introduction
Klaus Rübsamen is a notable inventor based in Neustadt, Germany. He has made significant contributions to the field of medical biotechnology, particularly in the development of innovative solutions for preventing tissue adhesions.
Latest Patents
Rübsamen holds a patent for "Recombinant fusion proteins for preventing or treating adhesions of tissues or organs." This invention involves recombinant fusion proteins that comprise a fibrinogenolytic enzyme linked to a high-molecular inert stabilization domain. The primary application of this invention is to prevent or treat adhesions, especially peritoneal adhesions that can occur following surgical interventions. He has 1 patent to his name.
Career Highlights
Klaus Rübsamen is associated with Akesion GmbH, where he continues to work on advancing medical technologies. His expertise in recombinant proteins has positioned him as a key figure in the biotechnology sector.
Collaborations
Rübsamen collaborates with Stephan Witte, contributing to the innovative projects at Akesion GmbH.
Conclusion
Klaus Rübsamen's work in developing recombinant fusion proteins showcases his commitment to improving surgical outcomes and advancing medical science. His contributions are vital in the ongoing efforts to enhance patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile